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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYStem-toxic small molecules have been developed to induce selective cell death of pluripotent stem cells (PSCs) to lower the risk of tera-
toma formation. However, despite their high efficacies, chemical-based approaches may carry unexpected toxicities on specific differen-
tiated cell types. Herein, we took advantage of KillerRed (KR) as a suicide gene, to selectively induce phototoxicity using visible light via
the production of reactive oxygen species. PSCs in an undifferentiated state that exclusively expressed KR (KR-PSCs) were eliminated by a
single exposure to visible light. This highly selective cell death in KR-PSCs was exploited to successfully inhibit teratoma formation. In
particular, endothelial cells fromKR-mPSCs remained fully functional in vitro and sufficient to repair ischemic injury in vivo regardless of
light exposure, suggesting that a genetic approach in which KR is expressed in a tightly controlled manner would be a viable strategy to
inhibit teratoma formation for future safe PSC-based therapies.INTRODUCTION
For more than a decade, multipotent stem cells have been
extensively studied for various cardiovascular diseases
such as heart failure and ischemic cardiomyopathy, which
was defined as the ‘‘first-generation’’ cell therapies (Behfar
et al., 2014). The ‘‘next-generation’’ cell therapies include
pluripotent stem cells (PSCs) such as human embryonic
stem cells (hESCs) and induced PSCs (iPSCs) in an effort
tomaximize therapeutic value of stem cells for cardiovascu-
lar diseases (Ban et al., 2014).
However, PSCs have major safety concerns, such as tera-
toma formation due to possible contamination of the resid-
ual undifferentiated PSCs (Lee et al., 2013a). Teratoma is a
unique characteristic of PSCs owing to their pluripotency
and ability to undergo unlimited proliferation (Gruen and
Grabel, 2006). These properties (e.g., pluripotency and lim-
itless proliferation), which theoretically allow the sufficient
supply of cardiomyocytes, cardiac progenitors, and endo-
thelial cells, make PSCs the most promising cell source for
regenerativemedicine (Robinton andDaley, 2012). The un-
limited proliferation capacity of PSCs is similar to the prolif-
eration of cancer cells, which results from high telomerase
activity (Thomson et al., 1998) and constant inhibition of
retinoblastoma protein (Burdon et al., 2002). Therefore,
the presence of a fewundifferentiated PSCs or incompletely
differentiated cells that escape the strict sorting process
would be a high risk factor for tumor development in safe
stem cell therapies (Masuda et al., 2014).Stem Cell RepHowever, teratoma or tumor formation following xeno-
transplantation of human (h)PSCs into animal models
(mostly rodents) has been barely reported (Kriks et al.,
2011; Laflamme et al., 2007), with a few exceptions (Bre-
derlau et al., 2006; Seminatore et al., 2010). A recent study
by Doi et al. (2012) demonstrated that extended differenti-
ation of hPSCs reduces the risk of teratoma formation in a
primate model. Therefore, stringent selection of differenti-
ated cells by flow cytometry for selective sorting (Cho et al.,
2007) or prolonged differentiation (Brederlau et al., 2006;
Zhang et al., 2001) would be sufficient to avoid tumorige-
nicity. Nevertheless, considering the ‘‘host-dependent
tumorigenicity’’ of ESCs (e.g., xenotransplantation of
hPSCs into a rodent model) (Erdo¨ et al., 2003), the risk of
teratoma formation by hPSCs in humans remains to be
resolved, especially given that several clinical trials of
hPSC-based therapies are ongoing (Cyranoski, 2013). Not
only mouse embryonic bodies (mEBs), but also differenti-
ated cells from mouse embryonic stem cells (mESCs) can
reportedly form teratomaswhen transplanted into a rodent
model, even after stringent cell sorting (Arnhold et al.,
2004; Fujikawa et al., 2005; Moon et al., 2013).
A number of approaches have been developed to reduce
the risk of teratoma formation, including antibody-based
selective elimination (Tang et al., 2011), small molecules
(Ben-David et al., 2013; Lee et al., 2013b), and integration
of a suicide gene (Li and Xiang, 2013). Among them, the
use of various chemicals to achieve selective cell death of
PSCs (referred as ‘‘stemotoxic’’ in a review, see Knoepfler,orts j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 The Authors 1067
2009) may have unexpected caveats, despite being highly
efficient (Knoepfler, 2009). Additionally, there is no evi-
dence indicating that such chemical treatment ensures
functionality of differentiated cells in vivo (Masuda et al.,
2014). Therefore, we attempted to eliminate undifferenti-
ated PSCs without using small molecules and reveal that
the differentiated cells after selective ablation of undiffer-
entiated PSCs remain fully functional in vivo. To this
end, KillerRed (KR), an artificial photosensitizer protein
derived from a hydrozoan chromoprotein (Bulina et al.,
2006) which produces reactive oxygen species (ROS)
when exposed to visible light of 540–580 nm (Wang
et al., 2012), was introduced into PSCs with a pluripo-
tent-specific promoter such that it was only expressed in
undifferentiated PSCs. A single treatment with visible light
successfully eliminated KR-expressing mouse PSCs (KR-
mPSCs) in an ROS-dependent manner, while endothelial
cells (ECs) differentiated from KR-mPSCs survived and re-
mained functional in vitro and in vivo. The similar results
were repeated in a human ESC (hESC) model. Importantly,
KR-mPSCs did not form teratomas after being exposed to
the light, whereas ECs differentiated from KR-mPSCs effec-
tively regenerated blood vessels under ischemic conditions
in a rodentmodel. Our results strongly support and provide
the ‘‘proof of concept’’ that a KR-based suicide gene
approach in which visible light selectively induces photo-
toxicity in PSCs would be an efficient strategy to reduce
the risk of tumorigenicity in PSC-based cardiovascular
repair.RESULTS
Establishment of KR-mPSCs
We aimed to induce selective cell death of undifferentiated
PSCs using visible light, which is supposedly harmless to
normal cells. We sought to specifically express KR, a photo-
sensitizer protein, in a pluripotency-dependentmanner. To
this end, we took advantage of previously developed plu-
ripotency-specific EOS (early transposon promoter and
OCT-4 and SOX2 enhancers) vector systems such as
EOS-C(3+) (Hotta et al., 2009), which contains multimer-
ized OCT-4 core enhancer element conserved region 4
(CR4) (Okumura-Nakanishi et al., 2005). KR expression
was designed to localize to mitochondria by adding amito-
chondrial-targeting sequence (MTS) (Figures 1A and 1B) to
maximize the induction of cell death via the production of
ROS (Rizzuto et al., 1995).
The constructed plasmid (EOS-C(3+)-KR) was delivered
to J1 mESC line (J1), and KR expressing mESCs were sorted
based on their red fluorescence (Figure 1C). KR-mESCs
formed teratomas consisting of ectodermal, mesodermal,
and endodermal tissues, suggesting that the introduction1068 Stem Cell Reports j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 Thof KR did not interfere with the pluripotency ofmESCs (Fig-
ure S1A). Similarly, EOS-C(3+)-KR was introduced into re-
programmable mouse embryonic fibroblasts (MEFs) (Carey
et al., 2010) and the cells were subsequently reprogrammed
by doxycycline treatment (Figure 1D). Consistent to previ-
ous reports (Hotta et al., 2009), the fully reprogrammed
cells were readily distinguished by their red fluorescence,
owing to activation of the EOS promoter as pluripotency
was acquired, in comparison with non-fluorescent control
mouse iPSCs (miPSCs) (Figures 1D, 1E, and S1B). The estab-
lished miPSCs expressing EOS-C(3+)-KR (KR-miPSCs)
formed teratomas, similar to KR-mESCs (Figure S1C).While
several typical pluripotency markers were equivalently ex-
pressed in KR-mESCs and KR-miPSCs compared with their
parental cells, KR was exclusively expressed in KR-mPSCs
(Figures 1F and 1G). These results indicate that the intro-
duction of KR did not impair the pluripotency properties
of PSCs.
Specific Expression of KR in a Pluripotent-Dependent
Manner
Red fluorescence from KR expression driven by activation
of the EOS-C(3+) promoter was distinct to KR-mPSCs (Fig-
ures 1C–1E); therefore, we next investigated whether
expression of KR was suppressed as KR-mESCs underwent
differentiation. Spontaneous differentiation of KR-mESCs
was induced through embryonic body (EB) formation fol-
lowed bymonolayer culture (Figure 2A, inserted). Red fluo-
rescence from KR was observed in the EB and gradually
diminished over time (Figure 2A). Consistently, KR expres-
sion was suppressed concurrent with Nanog and Oct-4 sup-
pression during spontaneous differentiation (Figure 2B).
KR protein level was also markedly suppressed during dif-
ferentiation (Figure S2A). Expression of marker genes of
all three germ layers (Fgf5: ectoderm, Brachyury: mesoderm,
and Sox17: endoderm) clearly increased in differentiated
cells (after 6 days of differentiation) (Figure 2B). Similarly,
red fluorescence from KR expression was only observed
in OCT-4-positive, not in OCT-4-negative populations
(cultured in a monolayer for 4 days after EB formation),
indicating that KR was specifically expressed in undifferen-
tiated PSCs (Figure 2C, white dotted line).
Induction of PSC-Specific Cell Death by Visible Light
KR expression was tightly controlled in a pluripotency-spe-
cific manner (Figure 2); therefore, irradiation with visible
light of 540–580 nm was expected to induce cell death
specifically in KR-mPSCs, not in differentiated cells. KR-
mESCs displaying red fluorescence were completely elimi-
nated within 6 hr after a single exposure to green light
(1.3 W/cm2, 540 nm), whereas control mESCs that did
not express KR had no apparent alteration (Figure 3A).
The phototoxic effects in KR-mESCs were quantified bye Authors
Figure 1. Establishment of KR-mPSCs
(A) Schematic presentation of the vector
used for stable transfection of mouse PSCs
expressing KR under the control of the
EOS-C(3+) promoter (mitochondrial target
sequence: MTS).
(B) KR-mESCs treated with mitotracker
(200 mM) for 45 min. The KR expression
(red) and mitochondria (by mitotracker,
green) co-localization was shown with DAPI
counterstaining. The scale bar represents
10 mm.
(C) Phase contrast image and red fluores-
cence of KR-mESCs (KR).
(D) Reprogramming progress of reprogram-
mable MEFs transfected with EOS-C(3+)-KR
plasmid observed by phase contrast and
fluorescence microscopy (KR).
(E) Phase contrast image and red fluores-
cence of KR-miPSCs (KR). The scale bar in
(C)–(E) represents 100 mm.
(F and G) Comparison of pluripotency
marker expression between established
mPSCs (Mock and KR). The results represent
the mean ± SD of two independent experi-
ments performed in triplicate.Annexin V/7-aminoactinomycin D (7-AAD) double stain-
ing. Around 90% of cells were positive for both Annexin
V and 7-AAD at 24 hr after light exposure (Figure 3B).
Apoptosis of KR-mESCs following light exposure was
further validated by the dramatic increase in caspase-3 ac-
tivity (Figure 3C). For clarification of the cell death rate of
KR-mESCs after light exposure, dead cells were counted fol-
lowed by trypan blue staining. The viability of light-
exposed KR-mESCswas close to 0%,whereas that of control
mESCs was slightly decreased after light exposure (Fig-
ure 3D). Morphological changes in KR-mESCs were exam-
ined at various time points after light exposure. Signs of
cell death were evident within 9–10 hr (560–660min) after
light exposure in KR-mESCs, but not in control mESCs
(Figure 3E; Movies S1 and S2). Similarly, KR-miPSCs were
also killed by light exposure, as determined by Annexin
V/7-AAD double staining (Figure S2B) and immunoblot
analysis (Figure S2C).Stem Cell RepROS Generation in KR-mPSCs after Light Exposure Is
Responsible for Phototoxicity
The phototoxicity of KR is owing to the generation of ROS
(Bulina et al., 2006). Considering the high susceptibility
of PSCs to oxidative damage (Han et al., 2008), ROS gen-
eration following KR activation was expected to be
strongly associated with the induction of KR-mPSCs’ cell
death. The level of ROS in KR-mESCs was monitored by
fluorescence microscopy (Figure 4A) and flow cytometry
(Figure 4B) using dichloro-dihydro-fluorescein diacetate
(DCF-DA) as a fluorescent probe. Following light expo-
sure, ROS generation was evident in KR-mESCs, but
not in control mESCs. KR-mPSCs were pretreated with
N-acetyl cysteine (NAC), a well-known antioxidant, prior
to light exposure in an attempt to block ROS-dependent
cell death. Apoptotic KR-mPSCs after light exposure,
with or without NAC pretreatment, were quantified by
fluorescence-activated cell sorting (FACS). This confirmedorts j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 The Authors 1069
Figure 2. Specific Expression of KR in a
Pluripotent-Dependent Manner
KR-mESCs differentiated with monolayer-
culture for 12 days after 3 days of EB
formation for spontaneous differentiation
(* indicates the day of sampling, inserted
panel).
(A) Red fluorescence from KR indicative
after differentiation monitored by phase
contrast and fluorescence microscopy. The
scale bar represents 100 mm.
(B) mRNA expression level of Oct-4, Nanog,
and KR at indicative day (* in Figure 2A,
inserted) during spontaneous differentia-
tion of KR-mESCs by qPCR (top). The typical
differentiation marker gene of three germ
layers; Fgf5 for ectoderm, Brachyury for
mesoderm, and Sox17 for endoderm
measured at 6 days of monolayer-culture
(bottom). The results represent the mean ±
SD of two independent experiments per-
formed in triplicate.
(C) KR-mESCs after 4 days of differentiation
protocol (*, inserted) were subject to im-
munostaining for OCT-4 with red fluores-
cence from KR (white dot line), DAPI for
nuclear counterstaining. The scale bar rep-
resents 50 mm.that ROS generation following light-induced KR activa-
tion induced KR-mPSCs’ cell death (Figure 4C). Consis-
tently, KR-mPSCs underwent cell death after light
exposure as determined by the detection of cleaved cas-
pase-3, which was prevented by pretreatment with NAC
(Figure 4D).
Specific Induction of Cell Death in KR-mPSC
We demonstrated that KR is specifically expressed in
pluripotent cells (Figure 2) and that ROS generation by
KR (Figures 4A and 4B) is responsible for phototoxicity in
KR-mPSCs (Figures 4C and 4D). Accordingly, it was hypoth-
esized that cell death effects would not be elicited in cells
differentiated from KR-mPSCs, in which KR expression
was strongly suppressed. Such a differential response to
visible light between KR-mPSCs and differentiated cells is
crucial if this approach is to be used to reduce the risk of
teratoma formation in clinical application. To test this,
we compared the cell death of KR-mPSCs and cells differen-
tiated from KR-mPSCs. When KR-mPSCs were partially
differentiated (Figure 5A, insert), a portion of cells re-
mained undifferentiated, according to their red fluores-
cence owing to KR expression (Figure 5A, top) and positive1070 Stem Cell Reports j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 Thstaining for stage-specific embryonic antigen-1 (SSEA-1;
Figure 5A, bottom).
After light exposure, only KR-expressing or SSEA-1-posi-
tive cells (undifferentiated PSCs) underwent cell death as
determined by the detection of cleaved caspase-3 (Fig-
ure 5A), indicating that only KR-mPSCs underwent cell
death by light exposure. Next, to quantify the light-depen-
dent cell death of differentiated cells and KR-mPSCs, FACS
analysis was performed of cells differentiated for 4 days
(Figure 5A, insert). Either SSEA-1 expression or red fluores-
cence was used to recognize undifferentiated KR-mPSCs.
Light exposure selectively induced cell death in those
that exhibited red fluorescence or were SSEA-1-positive
(Figure 5B). For tumor-free cell therapy to be achieved, re-
sidual undifferentiated PSCs should be depleted following
differentiation, as described in a previous study (Lee
et al., 2013b). At 24 hr after light exposure to cell mixture
from 4 days of differentiation (Figure 5A, insert), SSEA-1-
positive cells were markedly depleted by a single exposure
to light (Figure 5C).
As few as 500 mESCs are required to form a teratoma in a
mouse model (Erdo¨ et al., 2003), whereas at least 1 3 105
hESCs are required for teratoma formation in a micee Authors
Figure 3. Induction of PSC-Specific Cell
Death by Visible Light
KR-mESCs exposed to visual light, and the
rate of cell death 24 hr after light exposure.
(A) Number of KR expressing cells after light
exposure monitored by phase contrast and
fluorescence microscopy (KR). The scale bar
represents 100 mm.
(B and C) Apoptotic cell death of KR-mESCs
by light exposure determined by FACS
analysis for Annexin V and 7-AAD staining
(B) and caspase-3 enzyme activity assay
(C). The results represent one of the ex-
periments performed twice (for annexin V
staining) and thrice in duplicate plates (for
caspase-3 activity). The quantitative data
are mean ± SD (not significant: n/s and
***p < 0.001).
(D) Cell viability of control and light
exposed KR-mESCs determined by trypan
blue assay (more than 400 cells were
counted at each condition.) The results
represent the mean ± SD of two indepen-
dent experiments performed in duplicate.
(E) Morphological change of mESCs (Mock
and KR) at indicative time after light
exposure observed using a JuLI Smart
fluorescent cell analyzer microscope.xenograft model (Lee et al., 2009), possibly due to host-
dependent bias (Erdo¨ et al., 2003). For this reason, a mouse
teratoma model combined with mPSC transplantation is a
more suitable model to verify whether a strategy can
inhibit teratoma formation. Since iPSCs develop teratomas
more aggressively than ESCs, (Gutierrez-Aranda et al.,
2010), we first examined whether light exposure could
block teratoma formation by miPSCs. For maximization
of teratoma formation, 1 3 106 of KR-miPSCs, which
were exposed to light or not, were subcutaneously injected
into mice and teratoma formation was monitored. If more
than 500 injected cells survived following light exposure,
teratomas would develop (Erdo¨ et al., 2003). After
32 days, five of six mice injected with KR-miPSCs that
had not been exposed to light developed evident tera-
toma-like masses, whereas none of the mice injected withStem Cell RepKR-miPSCs that had been exposed to light developed tera-
toma-like masses (Figure 5D). Accordingly, the teratomas
formed by KR-miPSCs contained tissues of all three germ
layers (Figure 5E). In addition, 26 mice (14 and 12 mice
for control and light-exposed group, respectively) were
examined for determining teratoma formation. As consis-
tently, none of the mice developed teratoma after light
exposure prior to transplantation (0 of 12 mice) (Figures
5F and S5).
Light Exposure Does Not Affect the Function of ECs
Differentiated from KR-mPSCs In Vitro
Although selective cell death toward mPSCs was sufficient
to prevent teratoma formation (Figure 5), the function of
differentiated cells must be preserved to conceptually
prove that this approach has potential for future clinicalorts j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 The Authors 1071
Figure 4. ROS Generation in KR-mPSCs after Light Exposure Is Responsible for Phototoxicity
KR-mESCs exposed to visual light.
(A and B) The cells were incubated for 1 hr then stained with DCF-DA for 30 min. ROS levels were measured by fluorescence microscopy (A)
and flow cytometry (B). The scale bar in (A) represents 50 mm. The quantitative data represent mean ± SD of experiments performed in
three independent studies (**p < 0.01).
(C) mPSCs (Mock and KR) pretreated with 5 mM of NAC for 1 hr prior to the light exposure. Apoptotic cell death of mPSCs after light exposure
was determined by FACS analysis for Annexin V and 7-AAD dual staining. The results represent one of the experiments performed twice in
duplicate plates.
(D) Apoptotic cells monitored by immunostaining analysis for cleaved caspase-3 (green), DAPI for nuclear counterstaining. The scale bar
represents 100 mm.applications. To prove that light exposure, which specif-
ically induced the cell death of undifferentiated KR-mPSCs,
is suitable to safely isolate differentiated cells, we differen-
tiated KR-mESCs into ECs as described previously (Kim
et al., 2008). In sorted ECs, large granules of vonWillebrand
factor (vWF) were dispersed throughout the cytoplasm
(Figure S3A). The properties of ECs were briefly character-
ized by an acetylated low-density lipoprotein (Ac-LDL)
uptake assay (Figure S3B). ECs derived from KR-mESCs
(EC-KR-mESCs) remained functional after light exposure1072 Stem Cell Reports j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 Thas determined by in vitro assays of tubule formation (Fig-
ure 6A) and Ac-LDL uptake (Figure 6B), with no obvious
expression of active caspase-3 in any cells (Figure 6C). To
support the selective cell death of KR-mESCs, but not EC-
KR-mESCs, wemixed KR-mESCs prelabeled with CFSE fluo-
rescent dye with EC-KR-mESCs and then subjected the cell
mixture to the light exposure. Clearmorphological change,
indicating that cell death was manifested only in KR-
mESCs after light exposure, while no sign of change was
observed in EC-KR-mESCs (Movie S3). These data indicatee Authors
Figure 5. Specific Induction of Cell Death in KR-mPSC
(A) Immunostaining for KR or SSEA-1 (red) and cleaved caspase-3 (green) with DAPI (blue) for partially differentiated KR-mESCs (4 days
after monolayer culture, * inserted panel) with or without light exposure. The scale bar represents 100 mm.
(B) Apoptotic cell death analyzed by FACS analysis for cleaved caspase-3 and KR (or SSEA-1) in KR-mPSCs with or without light exposure.
The quantification of cleaved caspase-3-positive and -negative populations from KR (or SSEA-1) positive or negative populations is shown.
(C) Mixed cell population in 4 days monolayer culture of KR-mESCs (with SSEA-1+ and SSEA-1 population) exposed to visual light. Shown
are live cells of the SSEA-1+ and SSEA-1 population 24 hr after light exposure was determined by FACS analysis with SSEA-1 antibody
(black arrow indicates SSEA-1+ population, left). The number of SSEA-1+ population was quantified as a bar graph (right). The results
represent one of the experiments performed twice in duplicate plates.
(D) Introduction of KR-miPSCs with or without light exposure through subcutaneous injection. Representative images of teratomas from
KR-miPSCs with light exposure (0/6: zero out of six mice) and without (5/6: five out of six mice) are shown.
(E) Images of typical three germ layers from the teratoma stained with H&E staining, Masson’s trichrome, and Alcian Blue. The scale bar
represents 50 mm.
(F) Teratomas were counted and these tumor sizes were measured 30 days after injection of cells (14 and 12 mice for control and light
exposed group, respectively) (***p < 0.001).that EC-KR-mESCs are not susceptible to light-induced cell
death, unlike KR-mESCs.
Intact Vasculogenesis by EC-KR-mESCs without
Teratoma Formation after Light Exposure
EC-KR-mESCs were fully functional in vitro regardless of
light exposure (Figures 6A and 6B), and this supports the
notion that EC-KR-mESCs isolated after light exposure
would be an optimal cell source for recovery from ischemic
injury without the risk of teratoma formation. For investi-
gation of the therapeutic effects of EC-KR-mESCs, the cellsStem Cell Repwere injected into hindlimb ischemic models, with or
without light exposure. Changes in blood flow in the
ischemic hindlimb were determined by laser Doppler
perfusion imaging analysis at various time points. Blood
perfusion was markedly higher in ischemic hindlimbs in-
jected with EC-KR-mESCs, both exposed to light or not,
than in those injected with PBS (Figure 6D, top). At
24 days after cell transplantation, the blood flow ratio
(ischemic to non-ischemic limb), both EC-KR-mESCs
regardless of light exposure (n = 5), markedly increased in
comparison to the PBS group (n = 5) (Figure 6D, bottom).orts j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 The Authors 1073
Figure 6. Functionally Intact in Endothelial Cells from KR-mESCs In Vitro and In Vivo after Light Exposure
(A) Tubule formation and (B) Ac-LDL (red) uptake assay performed 24 hr after light exposure. The scale bars represent 200 mm (A) and
100 mm (B), not significant: n/s. The results represent one of the experiments performed thrice.
(C) Cell death in ECs 24 hr after light exposure determined by immunostaining for cleaved caspase-3 and DAPI nuclear counterstaining. The
scale bar represents 100 mm.
(D) Representative images of serial laser Doppler perfusion images (red to yellow) (top). Quantitative analysis of blood perfusion ratio of
ischemic to non-ischemic hindlimb at indicative days is shown as a line graph (bottom). Data are mean ± SEM.
(E) Physiological status of ischemic limbs 24 days after PBS or cell transplantation. Standard scoring image of hindlimb of Limb salvage,
Foot necrosis, Limb loss (top), and the recording number of cases for each condition with or without cell transplantation was summarized
as a table (bottom).
(F) Histological and immunohistochemical analyses of normal limbs and ischemic limbs retrieved 24 days after treatment. Tissue
regeneration and attenuated fibrosis were determined by H&E and trichrome Masson’s staining and detection of capillary formation was by
anti-PECAM in serial-sectioned tissues. The scale bar represents 200 mm (Normal and EC-KR-mESCs) and 500 mm (PBS).
(G) Testis injection of KR-mESCs (13 106 cells containing 50% of KR-mESCs and 50% of EC-KR-mESCs) 24 hr after light exposure, 8 weeks
after transplantation, representative images of teratoma mass (top) and normal testis (bottom) from mice transplanted with a cell
mixture.
(legend continued on next page)
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This difference was also obvious when assessing the histo-
logical status of ischemic limbs. Mice injected with EC-KR-
mESCs exposed to light showed a clear improvement in
limb salvage (n = 2/5) and foot necrosis (n = 3/5) compared
to mice injected with PBS, who exhibited extensive necro-
sis of the ischemic hindlimb and severe limb loss by au-
toamputation (n = 4/5) (Figure 6E). Histological analysis
was performed of muscle degeneration and fibrosis in
ischemic limbs at 24 days after injection of PBS (Figure 6F,
PBS) or EC-KR-mESCs exposed to light or not (Figure 6F,
Cont or Light exposure, respectively), as well as muscles
fromnon-ischemic limbs (Figure 6F, Normal). This revealed
thatmuscles of PBS-injectedmice displayedmassive degen-
eration, abnormal structures, and fibrosis in contrast to
EC-KR-mESC groups (Figure 6F). Similarly, platelet EC
adhesion molecule (PECAM) staining of serial-sectioned
tissues was performed to assess capillary formation in
ischemic areas, revealing that transplantation of EC-KR-
mESCs significantly enhanced the formation of PECAM-
positive capillaries (Figure 6F, white arrows). Moreover,
EC-KR-mESCs, prelabeled with dialkylcarbocyanime (DiI)
prior to engraftment, were observed in the ECs-trans-
planted tissue (Figure S3C). In particular, DiI positive cells
were found in the areawith smoothmuscle actin (SMA; Fig-
ure S3D, open arrows) staining (Figure S3D, closed arrows),
indicating that EC-KR-mESCs contribute to vasculogenesis
normally even after light exposure. These results highlight
the safety of light exposure to differentiated cells from
KR-mESCs.
For this strategy to be applicable to cell therapy, trans-
plantation of amixed population of cells containing undif-
ferentiated PSCs should not lead to teratoma formation
following light exposure. Finally, to verify that light expo-
sure prevents teratoma formation by KR-mESCs, a mixed
cell population (1 3 106 cells, 50% EC-KR-mESCs and
50% KR-mESCs) was exposed to light or not then trans-
planted into the mouse testis. As predicted, light exposure
prior to transplantation successfully inhibited the forma-
tion of teratomamass including all three germ-layer tissues
at 8 weeks after transplantation, whereas such masses were
seen in mice injected with cells that had not been exposed
to light (Figures 6G and S4). For statistical validation, the
same experiments were repeated with total 20 mice (10
mice for each group) and showed that none of mice devel-
oped teratoma after light exposure (Figures 6H and S6).
Most importantly, DiI prelabeled ECs were found in the
testis tissues from one with teratoma andwithout teratoma
(Figure 6I), suggesting that light exposure prior to cell injec-(H) Teratomas were counted and these tumor sizes were measured 5
group) (***p < 0.001).
(I) Fluorescent images of DiI (red) and DAPI (blue) for identifying ECs
in the separate images with high-magnification field of each area (ri
Stem Cell Reption, selectively ablates KR-mESCs, but not EC-KR-mESCs
(Figure 6H).Selective Cell Death by Light Exposure of KR-hESCs
We also established KR-expressing hESCs (KR-hESCs) based
on H9 hESCs using lentiviral transduction system as
described in experimental procedures (Figure 7A). For an
efficient sorting, EGFP was conjugated along with KR. As
shown in Figures 7B–7D, KR expression in KR-hESCs was
confirmed at mRNA level (Figure 7B) and protein level (Fig-
ures 7C and 7D) after cell sorting. As similar to the case of
mPSCs (Figures 1F and 1G), KR expression in hESCs gave
a marginal effect on the expression level of typical pluripo-
tency specific transcription factors such as OCT-4, SOX2,
and NANOG (Figure S7A). KR expression was suppressed
during differentiation as OCT-4 and NANOG expression
were decreased (Figure S7B). Upon visible light exposure,
KR-hESCs underwent cell death in a comparable manner
to that observed with mESCs (Figure 3), which was deter-
mined by morphological changes (Figure 7E), immuno-
blotting analysis (Figure 7F), and Annexin V staining
(Figure 7G). These data indicate that selective cell death
with KR expression and visual light exposure can be also
achieved in a hESC model.DISCUSSION
Many small molecules, including two reported by our
group (Lee et al., 2013b), have been suggested to be selec-
tively toxic to PSCs. However, as described previously
(Knoepfler, 2009), despite the high potency and efficacy
of small molecules that target hPSC-specific genes (e.g.,
BIRC5) (Lee et al., 2013b), there may be unexpected side
effects on certain differentiated cell types owing to unex-
pected expression of the particular target protein (e.g.,
BIRC5 expression in hematopoietic stem cells, see Leung
et al., 2007). Although the small molecules used in
previous studies had no significant effects on cellular
functions, at least those of dopaminergic neurons and
smooth muscle cells (Lee et al., 2013b), such possible
side effects need to be carefully examined for other small
molecules.
As selective cell death of undifferentiated hPSCs is crucial
to guarantee functional safety of differentiated cells during
a treatment, development of alternative strategies based on
unique gene expression and properties of undifferentiated
PSCs is required. In this respect, KR, which produces ROS1 days after injection of cells into total 20 mice (10 mice for each
and nucleus, respectively. The squares with dotted lines were shown
ght and left). The scale bar represents 100 mm.
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Figure 7. Selective Cell Death by Light
Exposure of KR-hESCs
(A) Schematic presentation of the lentiviral
vector used for stable transduction of hESCs
expressing KR under the control of the
EOS-S(4+) promoter (mitochondrial target
sequence: MTS).
(B) Comparison of KR expression between
established hESCs (GFP and KR) by
qPCR. The results represent the mean ±
SD of three independent experiments
(***p < 0.001).
(C) Green and red fluorescence of KR-hESCs
with DAPI counterstaining. The scale bar
represents 10 mm.
(D) Relative expression level of pluripo-
tency markers (OCT-4, SOX2, and NANOG)
between GFP and KR-hESCs by immuno-
blotting analysis.
(E) Light microscopic images of hESCs (GFP
and KR) 24 hr after light exposure. The scale
bar represents 500 mm.
(F) Cell death was determined by immuno-
blotting for PARP cleavage and a-tubulin
was used as an equal loading control.
(G) Flow cytometry plots of Annexin V and
7-AAD staining 24 hr after light exposure
(left) and a bar graph of relative level of
cell death population (right). The results
represent one of the experiments performed
twice.upon exposure to visible light of 540–580 nm (Bulina et al.,
2006), was synergized with the unique features of PSCs,
namely, their high sensitivity to oxidative stress (Han
et al., 2008) and high susceptibility to mitochondrial-
dependent apoptosis (Lee et al., 2013b) to develop an alter-
native strategy.
To this end, KR was expressed at the mitochondria (Fig-
ure 1B), and this expression was tightly controlled by
EOS-C(3+), an artificial pluripotent-specific promoter
(Okumura-Nakanishi et al., 2005) (Figure 2). ROS generated
upon exposure of KR to light specifically inducedmPSC cell1076 Stem Cell Reports j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 Thdeath (Figure 5), and the PSCs specific cell death by KR
expression blocked teratoma formation in a mouse model
(Figures 5 and 6). More importantly, EC-KR-mESCs were
functional in vitro and in vivo (Figure 6) after exposure to
light at an intensity that was sufficient to inhibit teratoma
formation (Figures 6G and 6H). This approach does not use
additional chemicals, unlike the typical suicide gene-based
approach, which uses thymidine kinase and ganciclovir,
which may have cell-type-dependent cytotoxicity (Rong
et al., 2012; Janoly-Dumenil et al., 2009) or hepatotoxicity
(Shea et al., 1987).e Authors
Despite numerous studies demonstrating that teratomas
do not form following xenotransplantation of cells differ-
entiated from hPSCs into a rodent model (Cho et al.,
2007; Kriks et al., 2011), review articles continue to warn
of the risk of teratoma or tumor formation in hPSC-based
therapies (Cunningham et al., 2012; Lee et al., 2013a). Cells
derived frommPSCs are apparently more prone to develop
tumors in amousemodel (Arnhold et al., 2004;Moon et al.,
2013), consistent with host-dependent bias (Erdo¨ et al.,
2003). Thereby, it is most appropriate to verify a teratoma
inhibition strategy using mPSCs in a mouse model to
exclude the host-dependent bias. Once the strategy is vali-
dated, it can be applied to hPSCs.
To this end, we also established KR-hESCs to examine se-
lective cell death by light exposure. Of interest, we noticed
that cell death rate by light exposure in KR-hESCs was
significantly lower compared to100% cell death achieved
in mESCs under the identical condition (Figure 3). We
reasoned that, unlike in mESCs (Figure S7D), KR protein
in hESCs underwent a consistent proteasome-dependent
degradation despite its high mRNA expression level
(Figure S7C). This notion was further supported by pre-
treatment of MG132, a proteasome inhibitor, which signif-
icantly increased KR protein level in KR-hESCs (Figure S7E).
Recently, it has been reported that hESCs show high pro-
teasome activity due to high expression of 19S proteasome
subunit (Vilchez et al., 2012). Considering a variety of
cellular and molecular differences between hESCs and
mESCs have been addressed by distinct characteristics of
the primed (for hESCs) and naive (for mESCs) state, respec-
tively (Nichols and Smith, 2009), the different protein
stability of KR between hESCs and mESCs might result
from the increased proteasome activity in hESCs, which
may be linked to distinct characteristics of the primed state
of ESC.
A recently developed gene-editing technology using
RNA-guided endonuclease (Gaj et al., 2013), which allows
the desired gene to be inserted into a genomic safe harbor
(GSH) area (Papapetrou et al., 2011), should be considered
to avoid undesirable random genomic insertion of EOS-
C(3+)-KR in the generation of hPSCs that do not give rise
to teratomas by simple light exposure. Especially, when
applied to generate KR-human iPSCs, guided insertion of
EOS-C(3+)-KR into the GSH area of parental cells allowed
for red fluorescence to be emitted when reprogramming
was complete to properly identify iPSC colonies (Hotta
et al., 2009), similar to the mouse model reported in the
current study (Figure 1D).
In summary, we demonstrated that expression of EOS-KR
in PSCs induces selective cell death specifically in undiffer-
entiated PSCs upon exposure to visible light and inhibits
teratoma formation without any additional chemical treat-
ment. ECs differentiated from KR-mESCs were able toStem Cell Reprepair ischemic damage after light exposure. Therefore,
this suicide gene-based approach represents a proof of
concept to generate a safe source of hPSCs that do not
give rise to teratomas or tumors.EXPERIMENTAL PROCEDURES
Details of the methods are available in the Supplemental Experi-
mental Procedures.
Generation of Transgenic PSC Clones
The KR backbone vector, designed to express at the mitochondria
(Bulina et al., 2006), was purchased from Evrogen (cat# FP964) for
transgenic mPSC clones. Another plasmid was reconstructed for
transgenic hESC clones using CSII-EF-EGFP lentiviral vector as a
backbone. A vector containing the coding sequence for a EOS-
C(3+) and -S(4+) cassettes (Hotta et al., 2009) were provided by
Dr. Kwang-Soo Kim (HarvardMedical School). The EOS-C(3+) cod-
ing sequence was amplified by PCR and sub-cloned into the linear-
ized KR backbone after the removal of CMV promoter in backbone
vector. The EOS-S(4+) sequence was sub-cloned at the front of
the KR sequence and then the EOS-S(4+)-KR cassette was sub-
cloned into the CSII-EF-EGFP lentiviral backbone vector. In the
resulting gene cassette, the EOS-C(3+) and -S(4+) promoters drive
KR expression.
MEFs from the reprogrammable mice ðGtðROSAÞ
26Sortm1ðrtTA
M2ÞJae Col1a1tm3(tetO-Pou5f1,-Sox2,-Klf4, and -Myc)Jae/J) (Carey
et al., 2010) was isolated in a standard protocol. J1 mouse ES cells
and reprogrammable MEFs were transfected with a EOS-C(3+)-KR
plasmid that had a neomycin gene that allowed for cell
selection. Cell transfection was performed using Neon Transfection
System (Life Technologies) according to the manufacturer’s instruc-
tions. Reprogrammable MEFs were transfected with EOS-C(3+)-KR
plasmid to induce KR and treated with 2 mg/ml doxycycline
(Sigma-Aldrich) to induce reprogramming. Culture medium was
replaced every 2 days by mouse ESC medium supplemented with
2 mg/ml doxycycline (Sigma-Aldrich). Positive colonieswere selected
formESC expressingKRusing 200 mg/mlof neomycin, and selection
of colony emitting red fluorescent colonies, and were maintained.
H9 hESCs were transduced with a CSII-EF-EGFP-EOS-S(4+)-KR
plasmid using lentiviral transduction system. EGFP and KR positive
cells were sorted by flow cytometry and maintained as previously
described (Lee et al., 2013b).
Endothelial Tube Formation andAc-LDLUptake Assay
Endothelial tube formation assay was performed by sorting EC-KR-
mESCs (5 3 104 cells), which were subsequently seeded on 4-well
matrigel-coated plates (BD Biosciences) and incubated at 37C for
12 hr. For the Ac-LDL uptake assay, EC-KR-mESCs were incubated
with 10 mg/ml DiI-labeled Ac-LDL (Biomedical Technologies) at
37C for 4 hr. After the cells were washed three times with PBS, im-
ages were analyzed using fluorescence microscopy (Nikon).
Teratoma Formation
The pluripotency of KR-mPSCs were examined in vivo through a
teratomaformationassayusing twodistinctmethods: subcutaneousorts j Vol. 5 j 1067–1080 j December 8, 2015 j ª2015 The Authors 1077
inoculation and direct testicular injection. First, 53 106 undifferen-
tiated KR-miPSCs (with or without light-exposure) were inoculated
subcutaneously under the right and left front leg of female
BALB/c-nude mice. There are two groups of light-exposed KR-
miPSCs (n = 12) and control KR-miPSCs (n = 14). For direct testicular
injection, undifferentiated KR-mESCs were mixed with EC-KR-
mESCs for a total count of 53 106 cells. Cell types were categorized
as KR-mESCs + EC-KR-mESCs (n = 10), and KR-mESCs + EC-KR-
mESCs (light, n = 10), and this routine was performed twice.
All light-exposed groups did not form teratomas except the
control KR-miPSCs group and KR-mESCs + EC-KR-mESCs group
that underwent subcutaneous injection and testicular injection,
respectively. All mice were euthanized 30 days or 51 days after the
inoculation for KR-miPSCs or mixed population, respectively.
Tumor volumes were calculated using the formula: V = a 3 b3 c3
p / 6 (a = length, b = width, and c = depth). All animal care and ex-
perimental procedures were performed under the approval of the
animal care committees in Konkuk University (IACUC No. KU
13125-1).
Hindlimb Ischemia Model and Cell Transplantation
The 6-week-old female nude mice (body weight 25-30 g) (Orient
bio) were anesthetized with rompun (20 mg/kg) and ketamine
(100 mg/kg). The femoral artery and its branches were ligated
through a skin incision with a 6-0 silk (Ethicon). The external
iliac artery and all of the above arteries were then ligated. The
femoral artery was excised from its proximal origin as a
branch of the external iliac artery to the distal point where it
bifurcates into the saphenous and popliteal arteries. Prior to
transplantation, cells were labeled with CM-DiI (DiI, Molecular
Probes) to detect survival and engraftment in vivo. The
number of mES-ECs (1 3 105 cells/mouse) were suspended in
200 ml of PBS then injected intramuscularly into four sites of
the gracilis muscle in the medical thigh with a 29-gauge insulin
syringe.
Statistical Analysis
The graphical data were presented as mean ± SD (error bars
represent the SD). Statistical significance among groups and
between groups were determined using one-way or two-way
ANOVA following Bonferroni post-test and Student’s t test, respec-
tively. Significance was assumed for p < 0.05(*), p < 0.01 (**), and
p < 0.001 (***).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and three movies and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2015.10.004.
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